Earnings Call · Q4 FY2025·2026-02-26

Q4 25EPS +42.97%·Rev n/aQ3 25EPS +38.71%·Rev n/aQ2 25EPS +51.61%·Rev n/aQ1 25EPS +38.89%·Rev n/a⚠ consensus missing

Teladoc Health, Inc. TDOC

Michael Minchak — Head of Investor Relations

Charles Divita — CHIEF EXECUTIVE OFFICER

+2.4%1d on move date+1.6% vs SPY3d+15.9%5d+12.3%

Research tier

Behavioral profile computed for 2 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more TDOC calls or request research access.

More TDOC calls Browse calls Request research access